AI-Designed Drug Rentosertib Shows Promise in Slowing Biological Aging

A drug candidate called rentosertib, developed with the assistance of artificial intelligence, was originally created to treat a rare lung condition. Early data suggests the drug may also reduce biological markers associated with aging. The findings come from the drug's maker, who reported these additional potential benefits beyond the primary lung indication. If validated, rentosertib could represent a notable example of AI's expanding role in pharmaceutical development.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.


Discussion (0)
Log in to join the discussion and vote.
Log in